Patients SURF302 Clinical Trial We are working to advance SURF302 our clinical study of dabogratinib for IR NMIBC. Please complete this form to receive updates. "*" indicates required fields First Name*Last Name*Email Address* Phone*What best describes you? (select one)*What best describes you? (select one) *I am a primary caregiver of a person with NMIBCI am a person with NMIBCI am a healthcare professionalI am a member of an advocacy related to NMIBCNone of the above applyI would like to learn more about the SURF302 Clinical Trial* Yes No
